Trials / Conditions / Indolent B-cell Lymphomas

Indolent B-cell Lymphomas

4 registered clinical trials studyying Indolent B-cell Lymphomas — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Multicenter Retrospective Observational Study of Relapsed Diffuse Large B-Cell Lymphoma Presenting As Indolent NCT06822829	Azienda USL Reggio Emilia - IRCCS	—
Completed	A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies NCT03329950	Celldex Therapeutics	Phase 1
Unknown	Efficacy and Safety of Ibrutinib in Patients With CLL and Other Indolent B-cell Lymphomas Who Are Chronic Hepa NCT02991638	The University of Hong Kong	Phase 3
Completed	Indolent Non Follicular Lymphomas Prognostic Project NCT02904577	Fondazione Italiana Linfomi - ETS	—